Sangamo Therapeutics (SGMOQ) Current Deferred Revenue (2009 - 2026)
Sangamo Therapeutics' Current Deferred Revenue came in at $402,000 for Q1 2026, down 94.7% from $7.56 million a year earlier and down 55.3% from the prior quarter.
Powered by 
Analysis
Sangamo Therapeutics (SGMOQ) Current Deferred Revenue (2009 - 2026) Analysis & Trends
At the end of FY2025, Sangamo Therapeutics' Current Deferred Revenue was $899,000, down 88.1% from FY2024.
- Current Deferred Revenue carries a five-year compound annual growth rate of -60.3% (FY2020 to FY2025).
- Going back by year, Current Deferred Revenue was $7.56 million in FY2024, $51.78 million in FY2022 (-39.6%) and $85.71 million in FY2021 (-6.5%).
- The Q1 2026 figure represents the lowest quarterly Current Deferred Revenue since Q4 2011.
- Year-over-year, Current Deferred Revenue increased in 1 of the last four quarters, with growth averaging 161.4%.
- The fastest year-over-year change in Current Deferred Revenue over five years came in Q3 2025 (growth of 876.2%), and the weakest in Q3 2023 (a decline of 97.9%).
- Business Quant data shows SGMOQ's Current Deferred Revenue at $899,000 (Q4 2025), $7.56 million (Q3 2025) and $7.56 million (Q2 2025) in the three quarters before Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Sangamo Therapeutics | 45.57 Mn | -70.94 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 402,000.00 |
| Dec 31, 2025 | 899,000.00 |
| Sep 30, 2025 | 7.56 Mn |
| Jun 30, 2025 | 7.56 Mn |
| Mar 31, 2025 | 7.56 Mn |
| Dec 31, 2024 | 7.56 Mn |
| Sep 30, 2024 | 774,000.00 |
| Sep 30, 2023 | 1.49 Mn |
| Jun 30, 2023 | 6.87 Mn |
| Mar 31, 2023 | 9.58 Mn |
| Dec 31, 2022 | 51.78 Mn |
| Sep 30, 2022 | 71.89 Mn |
| Jun 30, 2022 | 78.79 Mn |
| Mar 31, 2022 | 80.78 Mn |
| Dec 31, 2021 | 85.71 Mn |
| Sep 30, 2021 | 90.45 Mn |
| Jun 30, 2021 | 93.96 Mn |
| Mar 31, 2021 | 94.36 Mn |
| Dec 31, 2020 | 91.64 Mn |
| Sep 30, 2020 | 87.79 Mn |
API Access
Sangamo Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=SGMOQ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "SGMOQ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=SGMOQ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();